Search alternatives:
nsn decrease » nn decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
μ decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 nsn » 50 ns (Expand Search)
10 ng » 100 ng (Expand Search), 10 mg (Expand Search), 10 nm (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 μ (Expand Search)
nsn decrease » nn decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
μ decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 nsn » 50 ns (Expand Search)
10 ng » 100 ng (Expand Search), 10 mg (Expand Search), 10 nm (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 μ (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
GSK343 decreased tumor stemness.
Published 2021“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”
-
8
-
9
-
10
mGluR5 receptor decreased glycinergic currents.
Published 2019“…(<b>E</b>) The inhibitory effect of CHPG on GlyR-IPSCs was not blocked by intracellularly loaded GDP-β-S (62.3 ± 6.4% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.782, <i>p</i> = 0.032), chelerythrine (60.9 ± 11.3% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.705, <i>p</i> = 0.035), or Ro-32-0432 (69.9 ± 3.2% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 8.495, <i>p</i> < 0.001). (<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
-
11
-
12
ABT199 inhibits ALK <sup>mutant</sup> kinase activity and decreases it phosphorylation.
Published 2025Subjects: -
13
NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission.
Published 2025“…There were 3 mice per group, and 5 sections/animal and 4-5 images of each section were analyzed. …”
-
14
-
15
-
16
TUDCA decreases ER stress in HOX neonatal rat lungs.
Published 2022“…(<b>C</b>) In IHC stain, P-IRE1α levels are decreased (40.8±3.5 A.U. <i>vs</i> 53.1±5.0 A.U., p<0.001, n = 6, 3 for each sex) in chronic hyperoxia exposed neonatal rat lungs by TUDCA. …”
-
17
The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties.
Published 2020“…<i>n</i> = 4 oocytes for WT (EC<sub>50</sub> = 1.75 ± 0.04 μM) and 3 oocytes for C456Y (EC<sub>50</sub> = 1.86 ± 0.02 μM), <i>P</i> = 0.23, Mann-Whitney. …”
-
18
-
19
-
20